Stocktoria
Candel Therapeutics, Inc. CADL
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-27
Candel Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,093,905 | $11.3M | 1.99% |
| BlackRock Finance, Inc. | 823,071 | $5.1M | 1.5% |
| CITADEL ADVISORS LLC | 251,916 | $2.6M | 0.46% |
| Point72 Asset Management, L.P. | 129,183 | $1.3M | 0.24% |
| D. E. Shaw & Co., Inc. | 108,933 | $1.1M | 0.2% |
| TWO SIGMA INVESTMENTS, LP | 32,731 | $337,129 | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 20,417 | $210,296 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.